| | Effectiveness of Benzydamine Hydrochloride + Cetylpyridinium Chloride (Difflam®) Lozenges in Alleviating Sore Throat Among COVID-19 Patients: A Real-World Evidence Study in the Clinical Practice . . . |
Completed |
17 May 2023 |
| | Real World Effectiveness of Orphenadrine citrate 50 mg + Paracetamol 650 mg (Norgesic Forte TM) on Low Back Pain of Filipino Patients . . . |
Ongoing |
02 May 2023 |
| | Study of S-033188 Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications (CAPSTONE 2) . . . |
Completed |
28 May 2018 |
| | Efficacy and Safety of MYL-1402O Compared With Avastin in the First-line Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung
Cancer . . . |
Pending |
27 Jan 2017 |
| | A two-year, phase III randomized, double-blind, parallel-group, placebo-controlled trial to evaluate the safety, efficacy, and tolerability of 300 mg s.c. secukinumab versus placebo, in combination wi . . . |
Ongoing |
21 May 2021 |
| | Efficacy of Mandibular Advancement Device in the Treatment of Obstructive Sleep Apnea Syndrome among Filipinos Seen in a DOH Tertiary Hospital: A Pilot Study . . . |
Ongoing |
14 Apr 2016 |
| | EFFECTS ON POST-OPERATIVE PAIN REDUCTION IN CESAREAN SECTIONS (LOW MIDLINE INCISION) WITH THE USE OF CRYOTHERAPY: A RANDOMIZED CONTROL TRIAL . . . |
Ongoing |
13 Jul 2022 |
| | "A Phase III, Multicenter, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Sitagliptin in Pediatric Patients With Type 2 Diabetes Mellitus With Inade . . . |
Completed |
01 Apr 2022 |
| | 26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder (Most Recent Episode Manic) . . . |
Terminated |
27 Aug 2020 |
| | Effects of a 12-Week Virtual Arnis-based Exercise Program on Balance Control of Healthy Community-Dwelling Older Adults: A Pilot Randomized Study . . . |
Ongoing |
20 May 2022 |
| | Effects of Protein Drink A vs Protein Drink B on Testosterone, Anabolic Status, and Metabolic Hormone Profile of Young Men: A Repeated Measures Study . . . |
Completed |
12 Oct 2021 |
| | A multicenter, randomized, double-blinded, placebo-controlled Phase III trial to evaluate the efficacy, safety and immunogenicity of booster vaccination with recombinant two-compon . . . |
Ongoing |
17 Apr 2023 |
| | A RANDOMIZED OPEN LABEL PHASE 2B/3 STUDY OF THE SAFETY AND EFFICACY OF NP-120 (IFENPRODIL) FOR THE TREATMENT OF HOSPITALIZED PATIENTS WITH CONFIRMED COVID 19 DISEASE . . . |
Terminated |
19 Jul 2021 |
| | A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium to High-dose Inhaled Corticosteroid Plus Long- . . . |
Ongoing |
14 Sep 2022 |
| | Dose-finding, efficacy and safety of BI 655064 in patients with active lupus nephritis |
Completed |
04 Mar 2021 |
| | A 24-week randomized, open-label Study to evaluate the Safety and Efficacy of Fesoterodine in Subjects aged 6 to 17 Years with Symptoms of Detrusor Overactivity associated with a neurological Conditio . . . |
Completed |
14 Aug 2020 |
| | A Retrospective Comparison of Treatment Response between Short Course (6 months) and Extended Course (9 to 12 months) among Filipino Women with Genital Tract Tuberculosis who underwent Medical Managem . . . |
Completed |
07 Jan 2021 |
| | Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585) . . . |
Ongoing |
14 Sep 2022 |
| | Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) . . . |
Ongoing |
17 Sep 2021 |
| | A Global, Randomised, Phase 3, Open-label Study of REGN2810 (ANTI-PD 1 Antibody) Versus Platinum Based Chemotherapy in First Line Treatment of Patients With Advanced or Metastatic PD L1+Non-small Cell . . . |
Completed |
18 Aug 2022 |
| | A non-interventional, prospective 12-months study to characterize the REAL-life effectiveness and treatment patterns of SecukInumab and current standard of care in patient with chronic plaque psoriAsi . . . |
Completed |
19 Mar 2021 |
| | A Multi-center, Randomized, Double-blind, Placebo-controlled Phase II/III Clinical Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 Inactivated (Vero Cell) Vaccine in the Elderly 60-80 . . . |
Ongoing |
10 Feb 2021 |
| | Automated Auditory Brainstem Response Detection Device (HeLe): Safety and Efficacy Testing, Clinical Validation . . . |
Ongoing |
30 Nov -0001 |
| | Immunogenicity and Safety of Tetravalent Dengue Vaccine Given in 1 , 2 , or 3 Dose Schedules (STAGE I) Followed by a Single Booster Injection of the Same Vaccine (STAGE II) 1 or 2 Years After the Last . . . |
Completed |
14 Sep 2022 |
| | A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects with Neovascular Age-related Macular Degeneration . . . |
Terminated |
13 Oct 2021 |